Twin Tree Management’s MacroGenics MGNX Stock Holding History

Twin Tree Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-427	Closed	-$8K	–	1444
2019 Q1	$8K	Buy	+427	New	+$7.38K	﹤0.01%	1194

Other funds holding MGNX

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Twin Tree Management's MGNX Position: Q2 2019 in Review

Twin Tree Management sold out of MacroGenics (MGNX) in Q2 2019, closing a stake of 427 shares — an estimated $8K sold.

Twin Tree Management first reported a position in MGNX in Q1 2019 and held it in 1 quarter. The position peaked at $8K in Q1 2019. 130 funds tracked by Wall St. Rank hold MGNX as of Q2 2019.

Twin Tree Management reported no remaining MacroGenics position as of Q2 2019 after selling out during the quarter.
Twin Tree Management sold 427 MacroGenics shares in Q2 2019, an estimated $8K.
Twin Tree Management first reported a position in MacroGenics in Q1 2019 and held it in 1 quarter.
Twin Tree Management's MacroGenics position peaked at $8K in Q1 2019.
130 funds tracked by Wall St. Rank held MacroGenics as of Q2 2019.

Based on Twin Tree Management's 13F filing for Q2 2019, filed 12 Aug 2019.